SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-24-002967
Filing Date
2024-12-17
Accepted
2024-12-17 16:02:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g12927tara_12172024.htm SC 13G 234178
2 JOINT FILING AGREEMENT ex991to13g12927tara_121724.htm EX-99.1 15400
  Complete submission text file 0000921895-24-002967.txt   251365
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Subject) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88372 | Film No.: 241555594
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 100 NORTH MAIN STREET SUITE 301 ALPHARETTA GA 30009
Business Address 100 NORTH MAIN STREET SUITE 301 ALPHARETTA GA 30009 646-844-0037
Velan Capital Investment Management LP (Filed by) CIK: 0001848809 (see all company filings)

IRS No.: 844706623 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G